TIMP3 and fatty liver disease: The association of TIMP3 with liver steatosis is explained, but only in part by gut microbiome dysbiosis, suggesting that TIMP3/ADAM17 dyad exerts both broad and local effects to modulate immune and metabolic pathways9.